Lyten Completes Acquisition of Northvolt BESS Manufacturing Facility in Poland
16.10.2025 08:00:00 CEST | Business Wire | Press release
Lyten announces it has completed the acquisition of Northvolt Dwa in Gdańsk, Poland, the largest Battery Energy Storage System (BESS) manufacturing facility in Europe. Lyten is immediately restarting production and product development from Northvolt Dwa and targets sales before year end. Lyten is on track to complete the acquisition of the remaining Northvolt assets in Sweden and German in the 4Q 2025.
Lyten, the global leader in lithium-sulfur batteries and energy storage, announced today that it has completed its acquisition of Northvolt Dwa in Gdańsk, Poland. Northvolt Dwa is a 25,000-square meter (270,000-square foot) battery energy storage system (BESS) manufacturing and R&D facility that was opened in 2023. The facility includes equipment to ramp up to 6 GWh of energy storage manufacturing capacity and the ability to expand to up to 12 GWh in the future.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015600089/en/
Gdańsk, Poland – Lyten’s new Dwa Battery Energy Storage System (BESS) Manufacturing Facility, one of the largest BESS production sites in Europe. The site offers approximately 6 GWh of annual capacity, expandable up to 12 GWh.
The Northvolt Dwa acquisition accelerates Lyten’s entry in the rapidly growing BESS market. The Gdańsk location will serve as a major EU hub for Lyten’s BESS manufacturing and will export products to countries throughout the EU and across the world. Lyten intends to initiate the restart process immediately and to produce first commercial units off the line prior to year-end 2025.
“The Northvolt Dwa facility in Gdańsk is a world-class asset servicing the rapidly growing and strategically important BESS market. As demand for electricity continues its rise throughout the world to support AI and economic development, distributed energy storage will become increasingly critical,” said Dan Cook, Lyten CEO and Co-Founder. “We are seeing demand from across the world and are restarting production immediately to begin fulfilling orders before the end of the year.”
Lyten acquired Northvolt’s BESS product portfolio and intellectual property in the third quarter 2025. The first product to be produced at Northvolt Dwa is the Voltpack Mobile System (VMS). The 3rd generation family of modular BESS products is optimized for the rapidly growing commercial, industrial, and evolving data center markets.
Robert Chryc-Gawrychowski was recently announced as CEO of Lyten Poland and will lead operations at Northvolt Dwa. Robert was previously CEO of Northvolt Poland and led Northvolt’s efforts in Poland through the planning, construction, and startup of Northvolt Dwa.
Robert stated, “BESS is now a critical technology for energy security and economic development, and it is increasingly important that Europe is able to manufacture batteries locally. We are appreciative of the support of this acquisition by the Polish government at the city, provincial and national level and for their shared enthusiasm for Gdańsk as an important BESS hub for Europe.”
Andrzej Domański, Poland Minister of Finance and Economy, stated, “Lyten’s operations in Gdańsk are part of a broader process of developing advanced energy technologies in Poland and across Europe. International cooperation in this field supports knowledge transfer, innovation, and the growth of local industrial expertise. We support projects that contribute to building a sustainable and competitive economy.”
Aleksandra Dulkiewicz, President of Gdańsk, added, “For Gdańsk, Lyten's activities represent an opportunity to collaborate on the creation of energy innovation centers. We see many opportunities for cooperation – from research and development partnerships with universities, through pilot projects, to other activities aligned with Gdańsk's development strategy and national and regional economic specializations.
On August 7th, Lyten announced binding agreements to acquire all remaining Northvolt operations in Sweden, Poland, and Germany, with manufacturing assets totaling approximately $5 billion in book value. Close of the remaining Sweden and Germany acquisitions are expected to continue through the 4Q 2025.
About Lyten
Lyten, founded in 2015, is the global leader in lithium-sulfur batteries. It has received more than $625M in equity investment and secured LOIs for $650M in financing from the Export Import Bank of the US. Lyten’s US corporate headquarters is in San Jose, CA and its European corporate headquarters is in Luxembourg.
The company lists more than 540 patents granted or pending and is currently manufacturing in San Jose, CA. In November 2024, Lyten announced the acquisition of Northvolt’s battery manufacturing plant in San Leandro, California to scale production to meet the demand for American made batteries. In 2024, Lyten announced its integration into Chrysler’s Halcyon Concept electric vehicle. Lyten Lithium-Sulfur cells are demonstrating more than 3000 cycles under satellite testing protocols. Lyten is selling lithium-sulfur batteries commercially into the rapidly growing drone and defense market.
Lyten was named Fast Company’s #8 Most Innovative Energy Company and named one of America’s Top Green Technology Companies by Time in 2024, 2025, and been named to Silicon Valley Defense Journal’s Top 100 National Security Companies the third time in a row in 2025.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251015600089/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom